Vuja De Sciences Inc is a cutting-edge biotechnology company based in Hoboken, NJ, specializing in the detection and targeting of microscopic metastatic tumors, which are the primary drivers of cancer progression. Their innovative approach aims to identify and eliminate these hidden threats before they can lead to deadly metastatic recurrence, ultimately saving lives.
With a team of experienced professionals, including founder and CEO Dr. David Warshawsky, and laboratory director Dr. Scott Sauer, Vuja De Sciences is at the forefront of scientific operations and program management. Their groundbreaking research and development efforts are focused on revolutionizing cancer treatment and prevention, offering hope for a future where cancer can be effectively controlled and defeated.
Generated from the website